Search for cure against the lethal disease ALS boosted by new investor

  1. Home
  2. news
  3. Search for cure against the lethal disease ALS boosted by new investor

Search for cure against the lethal disease ALS boosted by new investor

Orphazyme closes a €14 million Series B Extension
Previous
Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders
Next

Recent Posts

  • Prilenia enrolls first ALS patient in their Phase II / III study
  • Emulate unveils brain chip to enhance neuroinflammatory disease research and drug discovery which will support drug development for ALS
  • Prilenia shows positive effect on functional capacity in Huntigton’s Disease
  • Orphazyme submits marketing authorization in Europe for the treatment of Niemann Pick Disease
  • Emulate signs a strategic partnership with the FDA

ROBERT BROWN

Scientific Advisory Board